Moderna (MRNA) has been a classic example of how one successful product can propel a biotech stock to new heights in a matter ...

Viking Global Investors' billionaire chief kicked Tesla to the curb in the December-ended quarter in favor of an ...

Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...

We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing ...

Flu cases are surging, especially among children, forcing a growing number of schools across the country to close. Elevated cases of COVID, RSV and norovirus are also overwhelming the health care ...